Bilateral intrahippocampal infusion of GQ1b, when administered after disease progression, restores cognitive impairments (Fig. 2) in 3xTg-AD mice accompanied by an increase in BDNF, but not NGF or NT-3 levels (Fig. 3A–D). This evidence concerns the gene BDNF and Alzheimer disease.